Mats Lindskog

Mats Lindskog Email and Phone Number

Chief Business Officer @ Oblique Therapeutics
Stockholm, SE
Mats Lindskog's Location
Greater Stockholm Metropolitan Area, Sweden, Sweden
Mats Lindskog's Contact Details

Mats Lindskog work email

Mats Lindskog personal email

n/a
About Mats Lindskog

Mats Lindskog is a Chief Business Officer at Oblique Therapeutics. He possess expertise in lifesciences, pharmaceutical industry, biotechnology, product management, cro and 11 more skills.

Mats Lindskog's Current Company Details
Oblique Therapeutics

Oblique Therapeutics

View
Chief Business Officer
Stockholm, SE
Website:
obliquet.com
Employees:
17
Mats Lindskog Work Experience Details
  • Oblique Therapeutics
    Chief Business Officer
    Oblique Therapeutics
    Stockholm, Se
  • Wntresearch Ab
    Board Member
    Wntresearch Ab May 2023 - Present
    Hovås, Se
  • Oblique Therapeutics
    Chief Business Officer
    Oblique Therapeutics Nov 2021 - Present
    Göteborg, Västra Götalands Län, Se
  • Inorbit Therapeutics
    Board Member
    Inorbit Therapeutics Jun 2023 - Oct 2024
  • Unimedic Pharma Ab
    Commercial Excellence Director / Senior Business Controller
    Unimedic Pharma Ab Sep 2020 - Nov 2021
    Stockholm, Se
  • Unimedic Pharma Ab
    Head Of Hospital Business Nordics
    Unimedic Pharma Ab Mar 2019 - Sep 2020
    Stockholm, Se
  • Allergan
    Head Of Business Excellence
    Allergan Aug 2018 - Mar 2019
    Dublin, Coolock, Ie
  • Shire
    Head Of Commercial Strategy And Operations, Nordics-Baltics
    Shire Apr 2016 - Jul 2018
    Tokyo, Jp, Jp
    Responsibilities: • Business planning and operations (performance / business reviews, brand planning, leadership team meetings, and launch excellence). • Member of Nordic-Baltic leadership team, European strategy and operations leads team and ad interim lead for emerging ophthalmology franchise. Reported directly to cluster head.
  • Shire
    Head Of Customer Excellence, Nordics-Baltics
    Shire Nov 2015 - Sep 2017
    Tokyo, Jp, Jp
    Responsibilities: • 10x direct reports, including commercial operations, analytics & insights, learning & development, CRM & sales force effectiveness, event planning, office management, and compliance & transparency reporting. • Interim assignment. Reported directly to cluster head.
  • Astrazeneca
    Nordic Sales Director Oncology
    Astrazeneca Dec 2013 - Oct 2015
    Cambridge, Cambridgeshire, Gb
    Responsibilities: • 8x direct reports and creation / implementation of commercial excellence projects (launch readiness, account planning, capability assessment, and field force training). • Member of Nordic-Baltic sales leadership team.
  • Astrazeneca
    Head Of Business Unit Oncology Nordics-Baltics
    Astrazeneca Feb 2014 - Sep 2014
    Cambridge, Cambridgeshire, Gb
    Responsibilities: • P&L responsibility for oncology business unit (11x direct reports, span of control: 26x people, 50MUSD revenue) as 8x month interim assignment. • Member of Nordic-Baltic leadership team and local compliance committee. Reported directly to cluster head.
  • Novartis
    Nordic Sales & Marketing Manager
    Novartis Apr 2012 - Dec 2013
    Basel, Baselstadt, Ch
    Responsibilities: • Commercial operations (marketing, sales, product launch, market access, and tender strategies / implementation) of biosimilars and non-substitutable generics. 3x direct reports.
  • Novartis
    Nordic Product Manager/Key Account Manager
    Novartis Mar 2011 - Apr 2012
    Basel, Baselstadt, Ch
    Nordic product manager with overall responsibility for Zarzio® (filgrastim) and Binocrit® (epoetin alfa). Member of the European brand team and involved in global brand strategies. KAM activities in Sweden. Responsible for collaborative projects with Novartis Oncology and Sandoz generics business unit.
  • Novartis
    Key Account Manager
    Novartis Nov 2010 - Mar 2011
    Basel, Baselstadt, Ch
    Sandoz biopharmaceuticals is the biosimilar business unit of Sandoz (the generics division of Novartis).Key account manager Sweden for Zarzio® (filgrastim). Excellent sales performance with Zarzio® overtook originator Neupogen® in 9 months after launch. Zarzio® succeeded still patented Neulasta® (pegfilgrastim) in 15 months. Sweden was first country to overtake Neupogen® and only country to succeed Neulasta®.
  • Amgen
    Product Manager
    Amgen Jan 2009 - Nov 2010
    Thousand Oaks, Ca, Us
    Amgen is a leading human therapeutics biotechnology company in the pharmaceutical industry.Product manager for biopharmaceuticals within oncology and hematology. Overall responsibility to maximize the brand potential for Neulasta® (pegfilgrastim), Neupogen® (filgrastim) and Vectibix® (panitumumab) with a combined yearly revenue of 23MUSD. Member of Swedish management team and budget responsibility for marketing and sales activites.
  • Sidec Ab
    Project Manager
    Sidec Ab May 2007 - Dec 2008
    Se
    Sidec is a CRO biotech company that provides Protein Tomography® to biotech/pharma industry used for IP protection and competitive positioning. Responsibilities: • Multiple customer projects (structural / binding analyses of antibodies) with European and U.S. pharma companies (Wyeth, Genmab, and Johnson & Johnson).Accomplishments:• Effective identification of antibody bindings and successful project deliveries resulted in offering of senior business development position in U.S.
  • Softseq Bioinformatics
    Ceo & Co-Founder
    Softseq Bioinformatics Jan 2005 - Jan 2007
    Small consulting firm specializing in Information Technology services within Life Science.

Mats Lindskog Skills

Lifesciences Pharmaceutical Industry Biotechnology Product Management Cro Market Access Biopharmaceuticals Hematology Urology Life Sciences Management Rheumatology Product Launch Oncology Pharmaceutical Sales Sales Effectiveness

Mats Lindskog Education Details

  • Blekinge Institute Of Technology
    Blekinge Institute Of Technology
    Ongoing
  • Stockholm University, Stockholm Bioinformatics Center
    Stockholm University, Stockholm Bioinformatics Center
    Machine Learning
  • Kth Royal Institute Of Technology
    Kth Royal Institute Of Technology
    Human Proteome Resource At Royal Institute Of Technology.
  • Kth Royal Institute Of Technology
    Kth Royal Institute Of Technology
    Biotechnology
  • North Attleboro High School, Ma, U.S.A.
    North Attleboro High School, Ma, U.S.A.
  • Rudbecks Gymnasium
    Rudbecks Gymnasium
  • Häggviksskolan
    Häggviksskolan

Frequently Asked Questions about Mats Lindskog

What company does Mats Lindskog work for?

Mats Lindskog works for Oblique Therapeutics

What is Mats Lindskog's role at the current company?

Mats Lindskog's current role is Chief Business Officer.

What is Mats Lindskog's email address?

Mats Lindskog's email address is ma****@****skog.nu

What schools did Mats Lindskog attend?

Mats Lindskog attended Blekinge Institute Of Technology, Stockholm University, Stockholm Bioinformatics Center, Kth Royal Institute Of Technology, Kth Royal Institute Of Technology, North Attleboro High School, Ma, U.s.a., Rudbecks Gymnasium, Häggviksskolan.

What skills is Mats Lindskog known for?

Mats Lindskog has skills like Lifesciences, Pharmaceutical Industry, Biotechnology, Product Management, Cro, Market Access, Biopharmaceuticals, Hematology, Urology, Life Sciences, Management, Rheumatology.

Who are Mats Lindskog's colleagues?

Mats Lindskog's colleagues are Daniela Papadia, Kjell H Andersson, Erika Vazquez Juarez, Marie Scherlund, Jessica Hägglund, Max Davidson.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.